FDA Resists Push For Longer Rulemaking Route On Lab-Developed Tests
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes to get a proposed regulatory framework for lab-developed tests out the door within a matter of months, but lab groups and other stakeholders are saying: slow down